#weight-loss-drug-safety

[ follow ]
fromIntelligencer
8 hours ago

Why Can't We Treat GLP-1's Like Medicine?

I learned early that autumn that I needed medicine, not an exorcism. An endocrinologist diagnosed type 2 diabetes (and it was 'serious,' he told me, gesticulating). High blood sugar had dried out my skin, making me itch; it had stolen my energy, sickened me in the heat, and caused my relentless hunger, or polyphagia.
Medicine
Health
fromABC7 Los Angeles
2 days ago

As unregulated peptides grow in popularity, doctors warn of unknown risks

Unregulated peptide injections are gaining popularity for healing and beauty, but their safety and effectiveness remain unproven.
Public health
fromwww.dw.com
1 day ago

WHO approves first Malaria drug for babies

A new malaria drug specifically for infants offers hope to reduce deaths among children under five, who account for two-thirds of malaria fatalities.
fromwww.npr.org
4 days ago

Restrictions on obesity drug coverage force patients to pivot

I was devastated. I had been able to get Zepbound for a $30 monthly copay and had lost 50 pounds in a year. The drug helped me focus on being a new mom and gaining strength at the gym, not just counting calories burned.
US news
Television
fromInsideHook
5 days ago

The Weird Trick That Makes You Want Less Junk Food

Viewing images of unhealthy food can reduce actual consumption among dieters due to a phenomenon called cross-modal satiation.
Psychology
fromwww.theguardian.com
5 days ago

What really controls our appetite hunger, stress or habit?

Hunger, appetite, and fullness are regulated by different brain areas, influencing our eating behaviors and responses to food.
SF food
fromwww.theguardian.com
6 days ago

My family tried to eat fewer ultra-processed foods for five years. Here's what we learned

Grocery shopping has shifted towards farmers' markets, focusing on fresh foods while spending more to avoid ultra-processed foods.
#glp-1-agonists
Medicine
fromFuturism
1 day ago

GLP-1 Drugs Linked to Cognitive Impairment, Though the Reason Why Probably Isn't What You Expect

GLP-1 agonists may increase the risk of cognitive impairment despite their other health benefits.
Medicine
fromwww.theguardian.com
1 month ago

The Guardian view on weight-loss jabs and addiction: there is too much moralising about these remarkable medicines | Editorial

Weight-loss drugs show promise in reducing addiction risk, suggesting they may address shared biological mechanisms between food and drug cravings in the brain.
Medicine
fromFuturism
1 day ago

GLP-1 Drugs Linked to Cognitive Impairment, Though the Reason Why Probably Isn't What You Expect

GLP-1 agonists may increase the risk of cognitive impairment despite their other health benefits.
Medicine
fromwww.theguardian.com
1 month ago

The Guardian view on weight-loss jabs and addiction: there is too much moralising about these remarkable medicines | Editorial

Weight-loss drugs show promise in reducing addiction risk, suggesting they may address shared biological mechanisms between food and drug cravings in the brain.
#glp-1-medications
Health
fromFast Company
1 month ago

New study of 77,000 patients reveals the hard truth about GLP1s

GLP-1 medications produce temporary weight loss; stopping treatment causes weight regain and return of metabolic complications within 1-2 years.
Medicine
fromScienceDaily
1 month ago

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.
Alternative medicine
fromFast Company
1 week ago

With GLP1 drug ads everywhere, here's what to know to safely buy them online

GLP-1 medications for weight loss are increasingly advertised, raising concerns about safety and the rise of unregulated alternatives.
Medicine
fromPsychology Today
2 weeks ago

The Dangerous Allure of Compounded GLP-1 Drugs

Compounded GLP-1 medications can be unsafe and unregulated, leading to serious health risks like acute liver failure.
Medicine
fromScienceDaily
1 month ago

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.
Health
fromwww.businessinsider.com
3 days ago

A top doctor doesn't use fitness trackers, but is obsessed with one health metric

Fitness trackers are generally unnecessary, but tracking step count can encourage daily activity.
#weight-loss
Psychology
fromPsychology Today
4 weeks ago

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.
fromwww.theguardian.com
3 weeks ago
Medicine

US approves new oral weight-loss pill developed by Eli Lilly

FDA approved orforglipron, a new oral weight-loss medication by Eli Lilly, offering an alternative to injectable GLP-1 treatments.
fromABC7 New York
3 weeks ago
Medicine

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.
Medicine
fromwww.dw.com
2 days ago

Natural molecule could provide Ozempic, Wegovy alternative

New weight-loss treatments like BRP may reduce side effects compared to existing drugs by targeting appetite regulation in the hypothalamus.
Psychology
fromPsychology Today
4 weeks ago

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.
Medicine
fromwww.bbc.com
2 weeks ago

New light shed on who benefits most from weight-loss jabs

Genetic variations in appetite and digestion can enhance weight loss effectiveness of drugs like Wegovy and Mounjaro.
Medicine
fromwww.theguardian.com
3 weeks ago

US approves new oral weight-loss pill developed by Eli Lilly

FDA approved orforglipron, a new oral weight-loss medication by Eli Lilly, offering an alternative to injectable GLP-1 treatments.
Medicine
fromABC7 New York
3 weeks ago

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.
#glp-1
Medicine
fromThe Atlantic
2 weeks ago

A Shot to Lose Weight, Then a Pill to Keep It Off

New GLP-1 pills are less effective than injections but offer convenience for long-term weight management.
Medicine
fromwww.businessinsider.com
3 weeks ago

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals.

Eli Lilly's Foundayo, a new weight loss pill, offers flexible dosing and outperforms competitors in weight loss and health metrics.
Medicine
fromThe Atlantic
2 weeks ago

A Shot to Lose Weight, Then a Pill to Keep It Off

New GLP-1 pills are less effective than injections but offer convenience for long-term weight management.
Medicine
fromwww.businessinsider.com
3 weeks ago

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals.

Eli Lilly's Foundayo, a new weight loss pill, offers flexible dosing and outperforms competitors in weight loss and health metrics.
Health
fromwww.theguardian.com
6 days ago

Is it true that only overweight people are at risk of high cholesterol?

High LDL cholesterol increases heart attack and stroke risk, influenced more by genetics than diet, with obesity affecting other blood lipids significantly.
from24/7 Wall St.
4 weeks ago

Wave Life Sciences Slips as Obesity Data Fails to Convince

The INLIGHT interim readout reported a 14.3% placebo-adjusted reduction in visceral fat six months after a single dose, alongside preservation of lean muscle mass - a differentiated profile compared to GLP-1 therapies that often reduce muscle alongside fat.
Cancer
fromwww.npr.org
3 weeks ago

The FDA approves a new obesity pill, giving patients another option

We've created a small molecule chemical which gets in your body very well. It can mimic the effects of the peptide and can be taken more conveniently any time of day without any food or water restrictions.
US news
#genetics
Medicine
fromwww.theguardian.com
2 weeks ago

Genetics may help explain why results from weight-loss jabs vary, say scientists

Genetic variations in gut hormone pathways may explain differing responses to weight-loss medications like GLP1 receptor agonists.
Medicine
fromNature
2 weeks ago

Why obesity drugs work better for some people: these genes hold clues

Genetic variants influence individual responses to obesity drugs, affecting weight loss and side effects.
Medicine
fromwww.theguardian.com
2 weeks ago

Genetics may help explain why results from weight-loss jabs vary, say scientists

Genetic variations in gut hormone pathways may explain differing responses to weight-loss medications like GLP1 receptor agonists.
Medicine
fromNature
2 weeks ago

Why obesity drugs work better for some people: these genes hold clues

Genetic variants influence individual responses to obesity drugs, affecting weight loss and side effects.
#glp-1-drugs
fromBusiness Insider
1 month ago
Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

fromFuturism
1 month ago
Medicine

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

fromBusiness Insider
1 month ago
Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

Medicine
fromFuturism
1 month ago

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

Stopping GLP-1 drugs can quickly reverse health benefits, increasing cardiovascular risks and leading to weight regain and other health issues.
Medicine
fromwww.theguardian.com
2 weeks ago

Is a new weight-loss drug making people fall out of love?

Retatrutide, an experimental weight-loss drug, may cause emotional flattening and affect relationships by dampening the brain's reward system.
#obesity
Medicine
fromWIRED
3 weeks ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
Medicine
fromWIRED
3 weeks ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
Public health
fromBBC
2 months ago

Inside Health - What are the side effects of weight loss drugs? - BBC Sounds

Weight loss drugs were used by over 1.5 million UK adults in 2024–25 and can cause side effects including nausea and painful gallstones.
fromwww.bbc.com
2 months ago

'I thought I was going to die' - Woman calls for tighter weight-loss jabs checks

Emma Dyer remembers the moment she clicked "buy now" on a set of weightloss jabs she found online. She had no medical consultation, no ID checks, and no questions about her history of anorexia and bulimia. "It was just so easy - too easy," she says. "They never asked for my medical history or what medication I was taking. It was like buying groceries."
Health
Public health
fromwww.bbc.com
2 months ago

Could weight-loss jabs be behind rising gallbladder removals?

Specialist doctors call for more research into a possible link between GLP-1 weight-loss injections and rising gallbladder removals and gallstones.
fromFortune
2 months ago

Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune

After having "constructive conversations with stakeholders," Hims decided to stop offering the treatment, the company said in a post on X Saturday.
Health
#glp-1-receptor-agonists
Medicine
fromNature
1 month ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
Medicine
fromNature
1 month ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
Health
fromIrish Independent
2 months ago

Real Health: From Stigma to Science: Aimee Donnellan on Ozempic

Weight-loss drugs like Ozempic rapidly shifted from a niche medical treatment to a global phenomenon reshaping business, society, and the food industry.
Medicine
fromwww.scientificamerican.com
1 month ago

Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial

Retatrutide, a triple-receptor GLP-3 agonist drug, achieved up to 36.6 pounds of average weight loss and improved blood sugar control in phase 3 clinical trials for type 2 diabetes.
#semaglutide
fromIndependent
1 month ago
Medicine

Luke O'Neill: Weight-loss drugs have been linked to sudden blindness, so how worried should you be?

fromIndependent
1 month ago
Medicine

Luke O'Neill: Weight-loss drugs have been linked to sudden blindness, so how worried should you be?

fromPsychology Today
1 month ago

We Need to Talk About the Fenfluramine Study

In the mid-1990s, child mental health researchers at top New York institutions injected grade-school boys with fenfluramine, also known as the diet drug "fen-fen," a substance that was later banned by the Food and Drug Administration, due to its links to valvular heart disease and pulmonary hypertension. The boys were all Black or Hispanic by design: Eligible participants were required to be African American or Hispanic because they were deemed to be at higher risk for developing disruptive behaviors.
Medicine
Medicine
fromIndependent
2 months ago

Are people spending less on food when they take weight-loss drugs?

Some individuals who can afford costly weight-loss medications may reduce household grocery spending significantly, offsetting part of the medication cost.
[ Load more ]